title: Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.
authors: Marcus
authors: M
authors: Y Chen
authors: Kerrie
authors: K
authors: Stevens
authors: Robin
authors: R
authors: Tideman
authors: Angelo
authors: A
authors: Zaia
authors: Takehiro
authors: T
authors: Tomita
authors: Christopher K
authors: CK
authors: Fairley
authors: Monica
authors: M
authors: Lahra
authors: David
authors: D
authors: Whiley
authors: Geoff
authors: G
authors: Hogg
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001315:Australia; D002443:Ceftriaxone / Q000627:therapeutic use*; D006069:Gonorrhea / Q000188:drug therapy* / Q000382:microbiology; D018451:Homosexuality, Male; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D010608:Pharyngeal Diseases / Q000188:drug therapy* / Q000382:microbiology; D010614:Pharynx / Q000382:microbiology; D012007:Rectum / Q000382:microbiology; D017211:Treatment Failure
chemical_list: D000900:Anti-Bacterial Agents; D002443:Ceftriaxone
keywords: Neisseria gonorrhoeae; antibiotics; gonococcal; pharynx; resistance